Managing the returns & reconciliation challenges of a Direct to Patient distribution model
Effective recruitment and retention is a fundamental building block of successful clinical trials management. It is also a large cost centre, with drug manufacturers investing an estimated $2.28 billion each year in recruiting study participants. Despite this, around two-thirds of clinical sites fall short of their enrollment quotas and the rate of patient drop-outs remains at approximately 30%.
This has given rise to a renewed industry focus on patient centricity. Promoting a positive patient experience is no longer just a moral obligation for sponsors, it’s a commercial one too. If recruitment is appropriately incentivised and patient convenience championed, enrollment can be accelerated, drop-outs and delays reduced, and revenues maximised.
Download this Case Study to find out moreView Resource
Almac Clinical Services
Guided by our extensive clinical supply experience and expertise, Almac Clinical Services is recognised as an innovative, global solution provider within the specialised and complex market of clinical trial supply.
Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.
Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.